The subject matter disclosed herein relates to biological indicators and, in particular to devices to break a biological indicator ampoule.
Medical devices are typically sterilized before use. Biological sterilization indicators, or biological indicators, are used to determine if a sterilization cycle has been efficacious. Typically, a sterilized medical device is not itself checked for contaminating organisms because such an activity could introduce other contaminating organisms to the medical device. An indirect check for contamination is performed using a biological indicator. A biological indicator is a device that is placed alongside or in proximity to a medical device being subjected to a sterilization cycle such that the biological indicator is subject to the same sterilization cycle as the medical device. For example, a biological indicator containing a predetermined quantity of microorganisms possessing known resistance to the sterilant can be placed into a sterilization chamber with the medical device. After the sterilization cycle is complete, the microorganisms in the biological indicator can be cultured to determine whether any of the microorganisms survived the sterilization.
Self-contained biological indicators contain a frangible vial, or ampoule, that contains a growth media and a housing that contains a quantity of microorganisms. The ampoule is located in the housing and separates the growth media from the microorganisms. After the sterilization cycle, the ampoule is broken to release the growth media into the housing so that it contacts the microorganisms. Examples of self-contained biological indicators have a housing in which one portion of the housing telescopes into another portion of the housing, which places pressure on, and breaks, the ampoule. Various methods are used to compress the housing with sufficient force to break the ampoule.
A device for breaking an ampoule of a biological indicator comprises a main body, a pivoting body attached to the main body at a main pivot point, a receiving area in the main body configured to receive the biological indicator, a pressing surface inside the pivoting body, and a compressing element including a compressing surface. The compressing surface may be operable between a first position and a second position located in the receiving area. A compression pivot point may also be provided and the compressing element may be attached to the pivoting body. The device may also include an urging member located between the main body and the compressing element that urges the compressing element against the pressing surface.
A device for breaking an ampoule of a biological indicator may alternatively comprise a main body, a pivoting body attached to the main body at a main pivot point, the pivoting body being pivotable between a rest position and a biological indicator compressing position, a receiving area configured to receive a biological indicator. The receiving area may extend in a longitudinal direction and having an end wall at one end of the receiving area in the longitudinal direction. The device may also include an angled surface inside the pivoting body, that is positioned at a positive angle relative to the longitudinal direction of the receiving area, such that the angled surface is closer to the end wall in the biological indicator compressing position than in the rest position. In this device, pivoting the pivoting body relative to the main body about the main pivot point causes the angled surface to move relative to the end wall.
A device for breaking an ampoule of a biological indicator may alternatively comprise a main body, a pivoting body attached to the main body at a pivot point, a first receiving area in the pivoting body configured to receive a first portion of a biological indicator, a retaining surface inside the pivoting body configured to receive an end of the biological indicator, and a pressing surface that moves with the main body and is located opposite the first receiving area, such that the pressing surface is closer to the retaining surface in the compressed position than in the rest position.
The device, in any of its embodiments, may assist a user to break an ampoule of a biological indicator to activate the biological indicator.
While the specification concludes with claims, which particularly point out and distinctly claim the subject matter described herein, it is believed the subject matter will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values±10% of the recited value, e.g. “about 90%” may refer to the range of values from 81% to 99%. In addition, as used herein, the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment.
Any of the examples or embodiments described herein may include various other features in addition to or in lieu of those described above. The teachings, expressions, embodiments, examples, etc., described herein should not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined should be clear to those skilled in the art in view of the teachings herein.
Having shown and described exemplary embodiments of the subject matter contained herein, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications without departing from the scope of the claims. In addition, where methods and steps described above indicate certain events occurring in certain order, it is intended that certain steps do not have to be performed in the order described but in any order as long as the steps allow the embodiments to function for their intended purposes. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Some such modifications should be apparent to those skilled in the art. For instance, the examples, embodiments, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative. Accordingly, the claims should not be limited to the specific details of structure and operation set forth in the written description and drawings.
The present application is a U.S. National Phase Application of International Application No. PCT/IB2021/060235, filed Nov. 4, 2021 which claims priority to U.S. Provisional Patent Application No. 63/112,069, filed Nov. 10, 2020. The entire contents of these applications are incorporated by reference herein in their entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2021/060235 | 11/4/2021 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2022/101750 | 5/19/2022 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2447988 | Pierson | Aug 1948 | A |
3346464 | Ernst | Oct 1967 | A |
3450319 | Ray et al. | Jun 1969 | A |
3752743 | Henshilwood | Aug 1973 | A |
3948727 | Steiger | Apr 1976 | A |
4291122 | Orelski | Sep 1981 | A |
4304869 | Dyke | Dec 1981 | A |
4528268 | Andersen et al. | Jul 1985 | A |
4537099 | Oster | Aug 1985 | A |
4546086 | Hounsell | Oct 1985 | A |
4637139 | Chen | Jan 1987 | A |
4717661 | McCormick et al. | Jan 1988 | A |
4732850 | Brown et al. | Mar 1988 | A |
4741437 | Gorski et al. | May 1988 | A |
4839291 | Welsh et al. | Jun 1989 | A |
4883641 | Wicks et al. | Nov 1989 | A |
4885253 | Kralovic | Dec 1989 | A |
5028543 | Finch et al. | Jul 1991 | A |
5073488 | Matner et al. | Dec 1991 | A |
5167923 | Van Iperen | Dec 1992 | A |
5223401 | Foltz et al. | Jun 1993 | A |
5252484 | Matner et al. | Oct 1993 | A |
5293816 | Musumeci, Sr. | Mar 1994 | A |
5362654 | Pouletty | Nov 1994 | A |
5405580 | Palmer | Apr 1995 | A |
5415994 | Imrich et al. | May 1995 | A |
5418167 | Matner et al. | May 1995 | A |
5482171 | Palmer | Jan 1996 | A |
5516648 | Malchesky et al. | May 1996 | A |
5552320 | Smith | Sep 1996 | A |
5736355 | Dyke et al. | Apr 1998 | A |
5739004 | Woodson | Apr 1998 | A |
5750184 | Imburgia | May 1998 | A |
5759848 | Nagoshi et al. | Jun 1998 | A |
5770393 | Dalmasso et al. | Jun 1998 | A |
5801010 | Falkowski et al. | Sep 1998 | A |
5830683 | Hendricks et al. | Nov 1998 | A |
5863790 | Bolea | Jan 1999 | A |
5866356 | Albert et al. | Feb 1999 | A |
5942438 | Antonoplos et al. | Aug 1999 | A |
6218189 | Antonoplos et al. | Apr 2001 | B1 |
6436659 | Hui et al. | Aug 2002 | B1 |
6458554 | Hui et al. | Oct 2002 | B1 |
6551555 | Antonoplos et al. | Apr 2003 | B2 |
6924139 | Eveland et al. | Aug 2005 | B2 |
7091042 | Lemus et al. | Aug 2006 | B2 |
7247482 | Lemus et al. | Jul 2007 | B2 |
7642067 | Song et al. | Jan 2010 | B2 |
8173388 | Pasmore et al. | May 2012 | B2 |
8173418 | Sestak | May 2012 | B2 |
8173438 | Putnam et al. | May 2012 | B1 |
8765398 | Dalmasso | Jul 2014 | B2 |
8840837 | Smith et al. | Sep 2014 | B2 |
8915413 | Kayser | Dec 2014 | B2 |
8945837 | Franciskovich et al. | Feb 2015 | B2 |
8969029 | Chandrapati et al. | Mar 2015 | B2 |
8980622 | Smith et al. | Mar 2015 | B2 |
9145573 | Pederson et al. | Sep 2015 | B2 |
9321973 | Marchand et al. | Apr 2016 | B2 |
9322046 | Chandrapati et al. | Apr 2016 | B2 |
9525317 | Ohashi et al. | Dec 2016 | B2 |
9675722 | Ahimou et al. | Jun 2017 | B2 |
9856124 | Mitidieri | Jan 2018 | B2 |
10059977 | Witcher et al. | Aug 2018 | B2 |
10150901 | Boutier et al. | Dec 2018 | B2 |
10561753 | Thompson et al. | Feb 2020 | B2 |
20040197848 | Behun et al. | Oct 2004 | A1 |
20050014214 | Eveland | Jan 2005 | A1 |
20080070272 | Franciskovich et al. | Mar 2008 | A1 |
20090068716 | Hirota et al. | Mar 2009 | A1 |
20110200992 | Chandrapati et al. | Aug 2011 | A1 |
20120149094 | Smith et al. | Jun 2012 | A1 |
20120156090 | Dane et al. | Jun 2012 | A1 |
20130210048 | Chandrapati et al. | Aug 2013 | A1 |
20130217107 | Pederson et al. | Aug 2013 | A1 |
20130224849 | Chandrapati et al. | Aug 2013 | A1 |
20130273594 | Ahimou et al. | Oct 2013 | A1 |
20150004682 | Smith et al. | Jan 2015 | A1 |
20150167047 | Smith et al. | Jun 2015 | A1 |
20150337354 | Ahimou et al. | Nov 2015 | A1 |
20160000954 | Ahimou et al. | Jan 2016 | A1 |
20170175071 | Sullivan et al. | Jun 2017 | A1 |
20170211035 | Yirava et al. | Jul 2017 | A1 |
20170253845 | Amin | Sep 2017 | A1 |
20180015193 | Swaminathan et al. | Jan 2018 | A1 |
20180071421 | Fang et al. | Mar 2018 | A1 |
20180187142 | Truong | Jul 2018 | A1 |
20180237821 | Fryer | Aug 2018 | A1 |
20190002951 | Fryer et al. | Jan 2019 | A1 |
20190106725 | Cregger et al. | Apr 2019 | A1 |
20190106726 | Cregger et al. | Apr 2019 | A1 |
20190169672 | Fryer et al. | Jun 2019 | A1 |
20200165658 | Bala et al. | May 2020 | A1 |
20210147784 | Amin | May 2021 | A1 |
Number | Date | Country |
---|---|---|
738687 | Jul 1966 | CA |
823163 | Sep 1969 | CA |
1 182 729 | Feb 1985 | CA |
1853734 | Nov 2006 | CN |
201453688 | May 2010 | CN |
102596261 | Jul 2012 | CN |
203307339 | Nov 2013 | CN |
105087361 | Nov 2015 | CN |
204814967 | Dec 2015 | CN |
105561362 | May 2016 | CN |
106267277 | Jan 2017 | CN |
106966348 | Jul 2017 | CN |
206473580 | Sep 2017 | CN |
206970617 | Feb 2018 | CN |
0 152 298 | Aug 1985 | EP |
1032822 | May 2003 | EP |
2968634 | Dec 2016 | EP |
2708287 | Oct 1995 | FR |
1055387 | Jan 1967 | GB |
201747012748 | Apr 2017 | IN |
201714046902 | Jul 2018 | IN |
H10201466 | Aug 1998 | JP |
H11196893 | Jul 1999 | JP |
2017123976 | Jul 2017 | JP |
2018201397 | Dec 2018 | JP |
129814 | Jul 2013 | RU |
143648 | Jul 2014 | RU |
146719 | Oct 2014 | RU |
2683644 | Apr 2019 | RU |
9219764 | Nov 1992 | WO |
9735189 | Sep 1997 | WO |
0050634 | Aug 2000 | WO |
2005036128 | Apr 2005 | WO |
2008106327 | Sep 2008 | WO |
2010039388 | Apr 2010 | WO |
2010045138 | Apr 2010 | WO |
2016057520 | Apr 2016 | WO |
2016205953 | Dec 2016 | WO |
2018025207 | Feb 2018 | WO |
2018160449 | Sep 2018 | WO |
2020136463 | Jul 2020 | WO |
2021053627 | Mar 2021 | WO |
Entry |
---|
NAMSA, Self-Contained Biological Indicators for Monitoring Steam, Northwood, Ohio, 2015. |
Anonymous, 3M™ Attest™ 1292E Rapid Readout Biological Indicator, Internet Article, Jan. 1, 1999, http://multimedia.3m.com/mws/mediawebserver?mwsld=SSSSSu7zK1fslxtU48_el8mGev7qe17zHvTSevTSeSSSSSS--&fn=Rapid_Readout_Profile_1292E.pdf. |
Chinese First Office Action and Search Report for Chinese Patent Application No. 201810004516.1 dated Aug. 3, 2020 and English translation. |
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for International Application No. PCT/IB2020/058750 dated Nov. 27, 2020, 1 page. |
PCT Written Opinion of the International Searching Authority for International Application No. PCT/IB2020/058750 dated Nov. 27, 2020, 6 pages. |
PCT International Search Report for International Application No. PCT/IB2020/058750 dated Nov. 27, 2020, 6 pages. |
Russian Search Report for Registration No. 2017145872/04(078515) dated Dec. 26, 2017, date of valid search completion: Jun. 10, 2021, 2 pages. |
PCT Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration for International Application No. PCT/IB2021/060235, dated Feb. 18, 2022, 9 pages. |
Verify SCBI HP Activator, Part No. LCB004, Steris Product No. LCB004 is a Verify Self-Contained Biological Indicator HP, 2 pages. |
Number | Date | Country | |
---|---|---|---|
20220411247 A1 | Dec 2022 | US |
Number | Date | Country | |
---|---|---|---|
63112069 | Nov 2020 | US |